Showing results (511-520 of 626) with videos related to

Sort By:
Pageof 63
Science (New York, N.Y.)|May 27, 2017
An on/off Berry phase switch in circular graphene resonatorsFereshte Ghahari, Daniel Walkup, Christopher Gutiérrez, et al.
Physical Biology|February 7, 2012
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumorsEdward H Cho, Marco Wendel, Madelyn Luttgen, et al.
Cancer Research|February 27, 2009
A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretionJavier Santos, Laura González-Sánchez, María Matabuena-Deyzaguirre, et al.
The Journal of Biological Chemistry|January 17, 2014
Structure and immunogenicity of a peptide vaccine, including the complete HIV-1 gp41 2F5 epitope: implications for antibody recognition mechanism and immunogen designSoraya Serrano, Aitziber Araujo, Beatriz Apellániz, et al.
ACS Applied Materials & Interfaces|October 24, 2024
Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER AntibodySara Insausti, Ander Ramos-Caballero, Brian Wiley, et al.
Experimental Physiology|August 6, 2025
Altered peripheral CRY1 gene expression may contribute to both organic and functional gastrointestinal diseaseSophie Fowler, Gemma M Paech, Emily C Hoedt, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
The Impact of Evolving Endometriosis Guidelines on Diagnosis and Observational Health StudiesHarry Reyes Nieva, Aparajita Kashyap, Erica A Voss, et al.
Acta Medica Philippina|March 18, 2026
Analysis of the Capacities of Health Facilities in the Eastern Visayas Region based on Health Care Provider Network Service Delivery GuidelinesLeizel P Lagrada, Romulo F Nieva, Alvin Duke R Sy, et al.
Oral Oncology|January 17, 2015
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinomaJill Gilbert, Michael J Schell, Xiuhua Zhao, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Pageof 63